Forced OTC Switch Impact On Consumers “Ambiguous” – MIT’s Berndt
This article was originally published in The Tan Sheet
Executive Summary
The impact of forced Rx-to-OTC switches on consumers "is uncertain and ambiguous and there is no clear gain in social welfare," MIT economics professor Ernst Berndt, PhD, says in recent comments to FDA